Ombudsman Ontario

Ombudsman Ontario

June 04, 2009 14:20 ET

Ombudsman to Investigate Ontario's Limited Funding of Cancer Drug

TORONTO, ONTARIO--(Marketwire - June 4, 2009) - Ontario Ombudsman Andre Marin has launched an investigation into the provincial Ministry of Health and Long-Term Care's funding of Avastin, a drug for colon cancer patients. The province's funding of Avastin is limited to 16 two-week cycles, regardless of patient response to the treatment. The Ombudsman is investigating whether the Ministry's decision to limit funding in this way was informed and reasonable.

The investigation will be conducted by the Special Ombudsman Response Team (SORT), the group of investigators responsible for major systemic investigations, such as the Ombudsman's recent probes into the lottery system, property taxation, newborn screening and the Special Investigations Unit.

SORT will conduct interviews with affected parties and review Ministry documentation relevant to the decision. Anyone with information relevant to the investigation may call the Ombudsman's complaint line at 1-800-263-4320.

Aussi disponible en francais

On the Web: www.ombudsman.on.ca

On Facebook: Ontario Ombudsman

On Twitter: twitter.com/Ont_Ombudsman

Contact Information